John Sfakianos

Search results

• Study Results from Mount Sinai Hospital in the Area of Diabetes Mellitus Reported (Higher Preoperative Egfr Is a Predictor of Worse Renal Function Decline After Robotic Assisted Radical Cystectomy: Implications for Postoperative Management)

  Reza Mehrazin,, John Sfakianos, Peter Wiklund & Daniel Ranti

  1/12/22

  1 item of Media coverage

  Press/Media

• Bladder Cancer Advocacy Network Announces $600,000 in Funding to Accelerate Bladder Cancer Research

  John Sfakianos

  11/07/22

  1 item of Media coverage

  Press/Media

• HCRN cancer researchers presented three studies during ASCO 2021

  Sudeh Izadmehr, Reza Mehrazin,, John Sfakianos & Sara Lewis

  9/06/21

  2 items of Media coverage

  Press/Media

• Localized Bladder Cancer Treatment Continues to Change: Expert Weighs In

  John Sfakianos

  21/03/20

  1 item of Media coverage

  Press/Media

• Fourth Annual Blue Jacket Fashion Show Included David Byrne, André Leon Talley, Dr. Mehmet Oz, Bill Nye And More for Men's Health And Prostate Cancer Awareness

  John Sfakianos

  6/02/20

  1 item of Media coverage

  Press/Media

• MDedge Hem-Onc Prostate Cancer RT eblast 5

  John Sfakianos, Bobby Liaw & Richard Stock

  26/11/19

  1 item of Media coverage

  Press/Media

• IBCN 2019: Muscle-Invasive Bladder Cancer Novel Mouse Model Capable of Orthotopic ...

  John Sfakianos

  7/10/19

  1 item of Media coverage

  Press/Media

• Fibroblast Growth Factor Receptor 3 Alterations and Response to PD-1/PD-L1 Blockade in Patients ...

  Yixuan Gong, John Sfakianos, Li Wang, Amir Horowitz, Nina Bhardwaj, David Mulholland & William Oh

  22/09/19

  1 item of Media coverage

  Press/Media

• Mount Sinai Receives $1.7 million to Study Natural Killer Cell Dysfunction in Bladder Cancer

  John Sfakianos, Ramon Parsons,, Nina Bhardwaj, Matthew Galsky, & Peter Wiklund

  12/09/19 → 13/09/19

  5 items of Media coverage

  Press/Media

• Mount Sinai Receives $1.7 Million to Study Natural Killer Cell Dysfunction in Bladder Cancer

  John Sfakianos, Ramon Parsons,, Nina Bhardwaj, Matthew Galsky, & Peter Wiklund

  12/09/19

  1 item of Media coverage

  Press/Media

• Quest for new cancer treatment crosses milestone

  John Sfakianos, Sara Lewis, Ardeshir Rastinehad,, Bachir Taouli & Ashutosh Tewari

  26/08/19 → 28/08/19

  11 items of Media coverage

  Press/Media

• Rice University: Quest for New Cancer Treatment Crosses Milestone

  John Sfakianos, Sara Lewis, Ardeshir Rastinehad,, Bachir Taouli & Ashutosh Tewari

  27/08/19

  1 item of Media coverage

  Press/Media

• QUEST FOR NEW CANCER TREATMENT CROSSES MILESTONE

  John Sfakianos, Sara Lewis, Ardeshir Rastinehad,, Bachir Taouli & Ashutosh Tewari

  26/08/19

  1 item of Media coverage

  Press/Media

• Article of the week: A transcriptomic signature of tertiary Gleason 5 predicts worse clinicopathological outcome

  Sujit Nair,, John Sfakianos, Ardeshir Rastinehad, & Peter Wiklund

  17/07/19

  1 item of Media coverage

  Press/Media

• Asieris completes patient enrollment in phase 1b trial of APL-1202

  John Sfakianos

  26/06/19

  1 item of Media coverage

  Press/Media

• Asieris Announces Completion of Enrollment for its US APL-1202 Phase Ib Clinical Trial

  John Sfakianos

  23/06/19 → 24/06/19

  14 items of Media coverage

  Press/Media

• Asieris Announces Completion of Enrollment for

  John Sfakianos

  24/06/19

  1 item of Media coverage

  Press/Media

• Asieris Completes Enrolment for US APL-1202 Phase Ib Clinical Trial

  John Sfakianos

  24/06/19

  2 items of Media coverage

  Press/Media

• Sen. Gianaris Speaks to the Greek-American Homeowners Association about Amazon (Vid)

  John Sfakianos

  4/04/19

  1 item of Media coverage

  Press/Media

• AUA 2018: Clinicopathological and Survival Analysis of Stage III/IV Papillary and Chromophobe ...

  Ketan Badani, & John Sfakianos

  25/05/18

  1 item of Media coverage

  Press/Media